The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
It was an event-filled one for biotech stocks, with the release of a slew of earnings, presentations of clinical trial results and M&A news flow.
Now, here are the upcoming week's key biotech catalysts.
Conferences
- 20th World Congress on Gastroenterology - March 4-5, in Berlin, Germany
- 18th International Conference on Nephrology & Urology - March 4-5, in Berlin
- 24th Annual meet on Surgical Oncology - March 4-5, in Paris, France
- 10th Molecular Immunology & Immunogenetics Congress - March 4-5, in Barcelona, Spain
- Credit Suisse 2019 Global Healthcare Conference – March 5-6, in London
- 32nd Euro Congress on Cancer Science & Therapy - March 7-8, in Barcelona
- 5th International Conference on Mental Health and Human Resilience - March 7-8, 2019 Barcelona
PDUFA Dates
The FDA is likely to rule on Johnson & Johnson (NYSE: JNJ) unit Janssen's treatment-resistant drug Esketamine Monday. A FDA panel that reviewed the investigational drug voted 14-2 in favor of its benefit-risk profile.
Clinical Trial Results
Sesen Bio Inc (NASDAQ: SESN) is due to release additional preliminary Phase 3 data for Vicinium, its treatment candidate for non-muscle invasive bladder cancer Monday.
Myokardia Inc (NASDAQ: MYOK) will release additional interim Phase 2 data for its non-obstructive hypertrophic cardiomyopathy candidate Mavacamten Monday.
Earnings
Monday, March 4
- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) (before the market open)
- Sesen Bio (before the market open)
- Myokardia (before the market open)
- Adamas Pharmaceuticals Inc (NASDAQ: ADMS) (after the market close)
- La Jolla Pharmaceutical Company (NASDAQ: LJPC) (after the market close)
- Otonomy Inc (NASDAQ: OTIC) (after the market close)
Tuesday, March 5
- Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (before the market open)
- Chimerix Inc (NASDAQ: CMRX) (before the market open)
- Obseva SA (NASDAQ: OBSV) (before the market open)
- Neuronetics Inc (NASDAQ: STIM) (before the market open)
- Fate Therapeutics Inc (NASDAQ: FATE) (after the market close)
- BIOLASE Inc (NASDAQ: BIOL) (after the market close)
- Kura Oncology Inc (NASDAQ: KURA) (after the market close)
Wednesday, March 6
- GlycoMimetics IncNASDAQ: (GLYC) (before the market open)
- Jounce Therapeutics Inc (NASDAQ: JNCE) (before the market open)
- OptiNose Inc (NASDAQ: OPTN) (before the market open)
- Xenon Pharmaceuticals Inc (NASDAQ: XENE) (after the market close)
- Assertio Therapeutics Inc (NASDAQ: ASRT) (after the market close)
- CareDx Inc (NASDAQ: CDNA) (after the market close)
- Evoke Pharma Inc (NASDAQ: EVOK) (after the market close)
See Also: Analysts Laud Sarepta's 'Increasingly Active' Gene Therapy Clinical Development
Thursday, March 7
- Orthopediatrics Corp (NASDAQ: KIDS) (before the market open)
- Albireo Pharma Inc (NASDAQ: ALBO) (before the market open)
- ArQule, Inc. (NASDAQ: ARQL) (before the market open)
- Zai Lab Ltd (NASDAQ: ZLAB) (before the market open)
- Syros Pharmaceuticals Inc (NASDAQ: SYRS) (before the market open)
- Celldex Therapeutics, Inc. (NASDAQ: CLDX) (after the market close)
- Kindred Biosciences Inc N(ASDAQ: KIN) (after the market close)
- Pure Bioscience, Inc. Common Stock (OTC: PURE) (after the market close)
- Ocular Therapeutix Inc (NASDAQ: OCUL) (after the market close)
- Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) (after the market close)
- AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) (after the market close)
- Aravive Inc (NASDAQ: ARAV (after the market close)
- Arbutus Biopharma Corp (NASDAQ: ABUS) (after the market close)
- Geron Corporation (NASDAQ: GERN) (after the market close)
- HTG Molecular Diagnostics Inc (NASDAQ: HTGM)
- Syndax Pharmaceuticals Inc (NASDAQ: SNDX)
Friday, March 8
- Allogene Therapeutics Inc (NASDAQ: ALLO) (before the market open)
- Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) (before the market open)
- PLx Pharma Inc (NASDAQ: PLXP) (before the market open)
IPO
ShockWave Medical, which sells medical devices to treat cardiovascular diseases, is set to offer 5 million shares in an IPO, with an estimated price range of $14-$16. The company expects to list its shares on the Nasdaq under the ticker symbol SWAV.
IPO Quiet Period Expiry
Alector Inc (NASDAQ: ALEC)
Harpoon Therapeutics Inc(NASDAQ: HARP)
Gossamer Bio Inc (NASDAQ: GOSS)
ANCHIANO THERAP/S ADR (NASDAQ: ANCN)
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Biotech Earnings News Previews FDA Top Stories Trading Ideas Best of Benzinga